sciences

Two Stocks in My Favorite Industry Sector

The Dow Jones has been zigzagging nearly all year long. Everyone knows that.Transportation stocks, basic materials and commodities have been sagging, even plunging. Most people know that, too.What many people may not be aware of — or may be underestimating — is the strength and sustainability of one key sector that’s been making investors money through thick and thin: health […]

Short Sellers Shy Away From Biotech Stocks – Benzinga

Related ALXNUS Stock Futures Drop Ahead Of Economic DataStrensiq Receives Marketing Approval in Japan for Treatment of Patients with HypophosphatasiaBy and large, the number of shares short in the leading biotech and emerging pharmaceutical stocks shrank between the June 15 and June 30 settlement dates.The trend was particularly noticeable in Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) and Gilead Sciences, Inc. (NASDAQ: […]

Biotech to break out, buy these names: Analyst – CNBC.com

While the stocks are not cheap, they’re not expensive, he added. What investors are paying for is high quality growth and high quality earnings.Read MoreCramer: Secret pattern to unlocking biotech richesIn fact, he thinks people have underappreciated biotech’s “fantastic” margins, noting that the companies now have 50 to 70 percent operating margins and “tons of real cash flow.””These are real […]

Capitalize on Comeback Stories in Micro-Cap Biotech Stocks :: The …

Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]

Biotech Stock Opportunities | Aoxing Pharmaceutical Company …

Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I see…Aoxing Pharmaceutical Company Stock Is […]

Financier looks to parlay a $5M Alzheimer’s deal into instant $172.5M IPO

Vivek Ramaswamy
Just before Christmas last year, a newly formed Bermuda-based biotech run by former hedge fund partner Vivek Ramaswamy struck a deal to in-license a shelved Alzheimer’s drug from GlaxoSmithKline ($GSK) with plans to put it into Phase III. That late-stage study won’t start until the fourth quarter, but the newborn biotech isn’t waiting around at the starting line. The […]

No, the Biotech Boom Isn’t Over

By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]

Why Smart Money Loves This Biotech Stock

Source: Amgen, Flickr.The biotech sector is something of a roulette wheel for investors. The chances of being right are typically against you, but if you can land a winner every now and then the rewards can multiply many times over your initial bet.A majority of the biotech sector is comprised of clinical-stage pipelines or developing product portfolios which are still […]

The Safest Biotech Bet on the Market

Source: “11g poker chips” by Logan Ingalls from South Boston, MA, USA. Licensed under CC BY 2.0 via Wikimedia CommonsGive up now if you’re looking for a totally safe biotech stock. They don’t exist.But if you’re looking for a biotech stock that is relatively safe compared to most others, that’s a different story. And there’s one biotech that is arguably the […]

Biotech stocks have been getting destroyed, but one analyst says the sell off is 'misguided'

View photo.(Wikimedia Commons)Some investors have been worried about a bubble in biotech stocks, and Wednesday’s sell off seemed to prove those fears.Biotech stocks fell more than 3%, their biggest one-day drop this year.But the industry is still one of the best-performing in the market: it’s up 35% over the past 12 months and 9.3% year-to-date, compared to year-to-date gains of 3% for the […]